Alan Lee Bazaar - 18 Jun 2024 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Jun 2024, 07:03:54 UTC
Prior SEC filing
12 Mar 2024
Next SEC filing
12 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Geoffrey Gillespie, attorney-in-fact

Key filing fact

Alan Lee Bazaar filed Form 4 for Orthofix Medical Inc. (OFIX) on 20 Jun 2024.

Key facts

  • This page summarizes Alan Lee Bazaar's Form 4 filing for Orthofix Medical Inc. (OFIX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 20 Jun 2024, 07:03.

Change

  • Previous filing in this sequence was filed on 12 Mar 2024.
  • Current net transaction value: +$195,006.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OFIX transaction

Common Stock

Award

Transaction value
$195,006
Shares
+15,152
Change %
+170%
Price
$12.87
Shares after
24,088
Date
18 Jun 2024
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

Footnote F2

Includes 24,088 deferred stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .